Trump Imposes 100% Tariff on Patented Drugs on 'Liberation Day'

The new tariff aims to lower drug prices, but critics warn it could limit access to vital medications.

Apr. 3, 2026 at 12:08am

Got story updates? Submit your updates here. ›

A close-up of a glass medicine bottle reflecting a warm, golden light, conceptually representing the high cost and limited access to prescription drugs.A new presidential tariff aims to lower drug prices, but critics warn it could restrict access to critical medications.NYC Today

President Donald Trump signed an executive order on Thursday that could impose a 100% tariff on certain patented drugs. The move is part of Trump's 'Liberation Day' initiative, which he claims will lower prescription drug costs for Americans. However, critics argue the tariff could restrict access to critical medications.

Why it matters

The high cost of prescription drugs has been a major political issue, with both parties promising to address the problem. Trump's tariff is an aggressive move to try to force down prices, but there are concerns it could backfire and limit availability of important medications.

The details

The executive order targets patented drugs that have no generic competition. The 100% tariff would apply to these drugs, potentially doubling their cost to consumers. Trump says the tariff will pressure pharmaceutical companies to lower their prices, but opponents warn it could lead to shortages and rationing of vital treatments.

  • The executive order was signed on Thursday, April 3, 2026.
  • The tariff is part of Trump's 'Liberation Day' initiative, which he has promoted since taking office.

The players

President Donald Trump

The 45th President of the United States, who signed the executive order imposing the 100% tariff on certain patented drugs.

Got photos? Submit your photos here. ›

What they’re saying

“We must not allow pharmaceutical companies to price gouge American patients any longer. This tariff will force them to lower their prices or lose access to our market.”

— President Donald Trump

What’s next

The executive order will likely face legal challenges from the pharmaceutical industry, who argue the tariff exceeds the President's authority and could violate international trade agreements.

The takeaway

Trump's aggressive move to lower drug prices through tariffs is a risky strategy that could backfire by limiting access to vital medications. The long-term impact on the pharmaceutical industry and American patients remains to be seen.